title: Increased annexin A1 and A2 levels in bronchoalveolar lavage fluid are associated with resistance to respiratory disease in beef calves.
abstract: Strategies to control bovine respiratory disease depend on accurate classification of disease risk. An objective method to refine the risk classification of beef calves could be economically beneficial, improve welfare by preventing unexpected disease occurrences, refine and reduce the use of antibiotics in beef production, and facilitate alternative methods of disease control. The objective of this study was to identify proteins in bronchoalveolar lavage fluid (BALF) of stressed healthy calves that predict later disease outcome, serve as biomarkers of susceptibility to pneumonia, and play a role in pathogenesis. BALF was collected from 162 healthy beef calves 1-2 days after weaning and transportation. Difference in gel electrophoresis (DIGE) and mass spectrometry were used to compare proteins in samples from 7 calves that later developed respiratory disease compared to 7 calves that remained healthy. Calves that later developed pneumonia had significantly lower levels of annexin A1, annexin A2, peroxiredoxin I, calcyphosin, superoxide dismutase, macrophage capping protein and dihydrodiol dehydrogenase 3. Differences in annexin levels were partially confirmed by western blot analysis. Thus, lower levels of annexins A1 and A2 are potential biomarkers of increased susceptibility to pneumonia in recently weaned and transported feedlot cattle. Since annexins are regulated by glucocorticoids, this finding may reflect individual differences in the stress response that predispose to pneumonia. These findings also have implications in pathogenesis. Annexins A1 and A2 are known to prevent neutrophil influx and fibrin deposition respectively, and may thus act to minimize the harmful effects of the inflammatory response during development of pneumonia.
authors.forename: Chandrika
authors.initials: C
authors.lastname: Senthilkumaran
authors.forename: Mary Ellen
authors.initials: ME
authors.lastname: Clark
authors.forename: Khaled
authors.initials: K
authors.lastname: Abdelaziz
authors.forename: Ken G
authors.initials: KG
authors.lastname: Bateman
authors.forename: Allison
authors.initials: A
authors.lastname: MacKay
authors.forename: Joanne
authors.initials: J
authors.lastname: Hewson
authors.forename: Jeff L
authors.initials: JL
authors.lastname: Caswell
mesh_terms: D000818:Animals; D017305:Annexin A1 / Q000235:genetics* / Q000378:metabolism; D017306:Annexin A2 / Q000235:genetics* / Q000378:metabolism; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry*; D002417:Cattle; D002418:Cattle Diseases / Q000209:etiology / Q000378:metabolism*; D060467:Disease Resistance; D004587:Electrophoresis, Agar Gel / Q000662:veterinary; D008297:Male; D016978:Mannheimia haemolytica / Q000502:physiology; D048089:Pneumonia of Calves, Enzootic / Q000378:metabolism / Q000382:microbiology*; D012140:Respiratory Tract Diseases / Q000209:etiology / Q000378:metabolism / Q000662:veterinary*; D053719:Tandem Mass Spectrometry / Q000662:veterinary
chemical_list: D017305:Annexin A1; D017306:Annexin A2
references.citation: Br J Pharmacol. 2002 Jan;135(2):511-9
references.pmid: 11815387
references.citation: Vet Immunol Immunopathol. 2011 Feb 15;139(2-4):113-8
references.pmid: 20932586
references.citation: Am J Respir Cell Mol Biol. 2004 Sep;31(3):322-9
references.pmid: 15130903
references.citation: J Cell Biol. 1994 Jul;126(2):539-48
references.pmid: 7518469
references.citation: Am J Respir Cell Mol Biol. 1995 Mar;12(3):280-6
references.pmid: 7873194
references.citation: Vascul Pharmacol. 2011 Mar-Jun;54(3-6):59-67
references.pmid: 21440088
references.citation: Am J Vet Res. 2012 Dec;73(12):1932-43
references.pmid: 23176420
references.citation: Vet Immunol Immunopathol. 2008 Sep 15;125(1-2):111-25
references.pmid: 18565593
references.citation: Vet Immunol Immunopathol. 2007 Aug 15;118(3-4):283-93
references.pmid: 17604846
references.citation: Vet Clin North Am Food Anim Pract. 2006 Jul;22(2):373-98
references.pmid: 16814023
references.citation: Neuroendocrinology. 1995 Nov;62(5):530-42
references.pmid: 8559285
references.citation: Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15571-6
references.pmid: 20713693
references.citation: FASEB J. 2003 Feb;17(2):253-5
references.pmid: 12475898
references.citation: Exp Mol Pathol. 2010 Apr;88(2):278-86
references.pmid: 20079732
references.citation: Oncotarget. 2011 Dec;2(12):1075-93
references.pmid: 22185818
references.citation: Paediatr Respir Rev. 2000 Mar;1(1):52-6
references.pmid: 16263445
references.citation: Biochem Biophys Res Commun. 1997 Nov 17;240(2):341-7
references.pmid: 9388479
references.citation: Proteomics. 2006 Dec;6(23):6354-69
references.pmid: 17133372
references.citation: J Am Soc Nephrol. 2012 Aug;23(8):1329-38
references.pmid: 22677557
references.citation: J Vet Diagn Invest. 2009 Jul;21(4):446-53
references.pmid: 19564492
references.citation: Nat Rev Immunol. 2009 Jan;9(1):62-70
references.pmid: 19104500
references.citation: FASEB J. 2003 Aug;17(11):1544-6
references.pmid: 12824302
references.citation: Eur J Biochem. 1979 Dec;102(1):147-52
references.pmid: 520319
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 Aug;293(2):L354-63
references.pmid: 17513451
references.citation: Mol Cell Biochem. 1992 Sep 22;115(1):79-84
references.pmid: 1435768
references.citation: J Immunol. 2007 Apr 1;178(7):4595-605
references.pmid: 17372018
references.citation: J Immunol. 2006 Apr 1;176(7):4410-8
references.pmid: 16547279
references.citation: Gut. 2004 Jul;53(7):993-1000
references.pmid: 15194650
references.citation: J Biol Chem. 1992 Aug 15;267(23):16545-52
references.pmid: 1322908
references.citation: Biochem Biophys Res Commun. 1997 Mar 17;232(2):407-13
references.pmid: 9125191
references.citation: J Cell Biol. 2001 Aug 20;154(4):775-84
references.pmid: 11514591